1. Dose optimisation of first-line tuberculosis drugs using therapeutic drug monitoring in saliva: feasible for rifampicin, not for isoniazid

   van den Elsen, S. H. J., Akkerman, O. W., Wessels, M., Jongedijk, E. M., Ghimire, S., van der Werf, T. S., Bolhuis, M. S., Touw, D. J. & Alffenaar, J-W. C., 2020, In : European Respiratory Journal.

   Research output: Contribution to journal › Article › Academic › peer-review

2. Therapeutic drug monitoring using saliva as matrix: an opportunity for linezolid, but challenge for moxifloxacin

   van den Elsen, S. H. J., Akkerman, O. W., Jongedijk, E. M., Wessels, M., Ghimire, S., van der Werf, T. S., Touw, D. J., Bolhuis, M. S. & Alffenaar, J-W. C., 1-May-2020, In : European Respiratory Journal. 55, 5, 4 p., 1901903.

   Research output: Contribution to journal › Letter › Academic › peer-review

3. Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules

   Bolhuis, M. S., van der Werf, T. S., Kerstjens, H. A. M., de Lange, W. C. M., Alffenaar, J-W. C. & Akkerman, O. W., 1-Dec-2019, In : European Respiratory Journal. 54, 6, 4 p., 1900580.

   Research output: Contribution to journal › Letter › Academic › peer-review

4. Reduced moxifloxacin exposure in patients with tuberculosis and diabetes

   Dekkers, B. G. J., Bolhuis, M. S., Ter Beek, L., de Lange, W. C. M., van der Werf, T. S., Alffenaar, J-W. C. & Akkerman, O. W., 2019, In : European Respiratory Journal. 54, 3, 4 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

5. Tuberculosis-related Malnutrition: Public Health Implications

   Ter Beek, L., Alffenaar, J-W. C., Bolhuis, M. S., van der Werf, T. S. & Akkerman, O. W., 15-Jul-2019, In : The Journal of Infectious Diseases. 220, 2, p. 340-341 2 p.

   Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

View all (43) »

1. European Society for Developmental Perinatal and Pediatric Pharmacology

   Mathieu Bolhuis (Participant)

   28-May-2019 → 30-May-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

2. QMUL TB webinar

   Mathieu Bolhuis (Invited speaker)

   2019 → 2020

   Activity: Participating in or organising an event › Participation in conference › Academic

3. 1st International Blizard/QMUL Tuberculosis Symposium

   Mathieu Bolhuis (Invited speaker)

   26-Jun-2019

   Activity: Participating in or organising an event › Participation in conference › Academic

View all (21) »